Digimarc Reports Third Quarter 2026 Financial Results

Digimarc Corp (DMRC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Digimarc Reports Third Quarter 2026 Financial Results Narrowing our Aperture to Accelerate Beaverton, Ore. – November 12, 2026 – D igimarc Corporation (NASDAQ: DMRC) reported financial results for the third quarter ended September 30, 2026 . "Last quarter we said our

Original reporting
Published Nov 12, 2026, 9:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$DMRC
Bearish
high confidence
Mentioned
$DMRC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$DMRCBearishMed
01

Why it matters

The earnings miss could trigger short‑term sell‑off, but the improved gross margins and reduced operating expenses may support a longer‑term view.

02

Market read

First‑time disclosure of Q3 2026 results for a micro‑cap; provides fresh data for traders.

03

What to watch

Cash balance rose to $22.1M, providing runway for strategic initiatives.

Relevance 7/10Novelty 8/10Timing: same day

Background

Digimarc Corp (NASDAQ: DMRC) filed a Form 8‑K reporting its third‑quarter 2026 financial results.

Company-level read

Ticker impact

$DMRCBearishHigh confidence
Context

Q3 2026 revenue fell to $6.4M (down 16%) and net loss widened to $8.1M, indicating weaker performance.

Expected impact

likely pressure as the market prices in the revenue decline and widening loss

Evidence & confidence

The 8‑K filing is the first public disclosure of the numbers; the drop in revenue and ARR suggests short‑term downside for the stock.

Market effects

Signals weakness in the digital identity and anti‑fraud niche, potentially affecting peer valuations.

Limited to U.S. micro‑cap segment; no broader regional effect.

Low; the company is a niche player with minimal global market influence.

Counterpoint

If the company can convert pipeline contracts to recurring ARR quickly, the dip may be temporary.

Key entities

  • Paul Carreiro

    CEO of Digimarc, quoted on execution focus.

  • Charles Beck

    CFO of Digimarc, co‑host of the earnings call.

Related articles

$DMRCMed

Digimarc Reports Second Quarter 2026 Financial Results

Digimarc Corp (DMRC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Digimarc Reports Second Quarter 2026 Financial Results Narrowing our Aperture to Accelerate Beaverton, Ore. – August 13, 2026 – D igimarc Corporation (NASDAQ: DMRC) reported financial results for the second quarter ended June 30, 2026 . "We are already starting to se

$NOKMed

LightCounting:: November 2026 Nokia SReXperts

Nokia hosted its SReXperts/Wavelengths conference in November 2026, focusing on AI's impact on connectivity and its solutions for customers. The company reported strong Q3 2026 earnings, with AI & Cloud sales doubling year-over-year and $1.7 billion in new orders. Nokia expects 25-30% growth in its Optical and IP Networks businesses in 2027. The company aims to help telecom operators adapt to AI-driven changes and capitalize on new opportunities.

$IBRXLow

IBRX Stock Eyes Best Year Ever: Founder Teases 12 Months Of ‘Stealth’ NantWorks Reveals — Cancer Tech, AI Chips And Satellites

ImmunityBio (IBRX) reported a 53% increase in Q3 net product revenue to $48.7M, with 92% growth for the first nine months. The company is testing its drug Anktiva for sepsis and aims to expand FDA approval for bladder cancer. NantWorks, led by Patrick Soon-Shiong, plans a blockchain-based exchange for tokenized securities. IBRX stock has risen 195% over the past year, with bullish retail sentiment on Stocktwits.